Use of 2-(3,4-dimethoxycinnamoyl)aminobenzoic acid for the...

Details Use of 2-(3,4-dimethoxycinnamoyl)aminobenzoic acid for the... Use of 2-(3,4-dimethoxycinnamoyl)aminobenzoic acid for the...

A - Human Necessities

61

K

A61K 31/195 (2006.01) A61K 31/19 (2006.01)

Patent

CA 2106172

This invention provides a pharmaceutical composition for the treatment or prevention of restenosis associated with coronary intervention, containing, as an active ingredient, 2-(3,4-dimethyoxycinnamoyl)aminobenzoic acid or a pharmaceutically acceptable salt thereof and the use of 2-(3,4-dimethoxycinnamoyl)aminobenzoic acid or a pharmaceutically acceptable salt thereof for the manufacture of a pharmaceutical for the treatment or prevention of restenosis associated with coronary intervention. A 600 mg dosage of 2-(3,4-dimethoxy- cinnamoyl)aminobenzoic acid for a treatment period of three consecutive months after coronary intervention lowers the incidence of restenosis, and reduces the degree of stenosis in patients.

Affiliated with

Also associated with

Rating

Use of 2-(3,4-dimethoxycinnamoyl)aminobenzoic acid for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of 2-(3,4-dimethoxycinnamoyl)aminobenzoic acid for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 2-(3,4-dimethoxycinnamoyl)aminobenzoic acid for the... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1374133